Literature DB >> 25982416

Exploring S1 plasticity and probing S1' subsite of mammalian aminopeptidase N/CD13 with highly potent and selective aminobenzosuberone inhibitors.

Germain Revelant1, Mira Al-Lakkis-Wehbe1, Marjorie Schmitt2, Sarah Alavi1, Céline Schmitt1, Lionel Roux1, Mounir Al-Masri1, Nadège Schifano-Faux1, Carmen Maiereanu1, Céline Tarnus1, Sébastien Albrecht3.   

Abstract

In order to probe the S1 and S1' mammalian aminopeptidase N subsites, racemic 1- or 4-substituted 7-aminobenzocyclohepten-6-one derivatives were synthesized and evaluated for their ability to inhibit mammalian aminopeptidase N. We focused on improving the physicochemical and ADME properties of this series by targeting lipophilicity and LELP score. Some 4-heteroaryl substituted analogues displayed reduced lipophilicity and enhanced inhibition potency with Ki values in the nanomolar range.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aminopeptidase N inhibitors; Cancer; Racemic 1- or 4-substituted aminobenzocycloheptenone derivatives; Suzuki reaction

Mesh:

Substances:

Year:  2015        PMID: 25982416     DOI: 10.1016/j.bmc.2015.04.066

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Allosteric inhibition of aminopeptidase N functions related to tumor growth and virus infection.

Authors:  César Santiago; Gaurav Mudgal; Juan Reguera; Rosario Recacha; Sébastien Albrecht; Luis Enjuanes; José M Casasnovas
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

2.  Computational study of novel natural inhibitors targeting aminopeptidase N(CD13).

Authors:  Junliang Ge; Zhongfeng Wang; Ye Cheng; Junan Ren; Bo Wu; Weihang Li; Xinhui Wang; Xing Su; Ziling Liu
Journal:  Aging (Albany NY)       Date:  2020-05-09       Impact factor: 5.682

3.  Aminobenzosuberone Scaffold as a Modular Chemical Tool for the Inhibition of Therapeutically Relevant M1 Aminopeptidases.

Authors:  Emmanuel Salomon; Marjorie Schmitt; Anil Kumar Marapaka; Athanasios Stamogiannos; Germain Revelant; Céline Schmitt; Sarah Alavi; Isabelle Florent; Anthony Addlagatta; Efstratios Stratikos; Céline Tarnus; Sébastien Albrecht
Journal:  Molecules       Date:  2018-10-11       Impact factor: 4.411

4.  Development of pyrazoline-based derivatives as aminopeptidase N inhibitors to overcome cancer invasion and metastasis.

Authors:  Jiangying Cao; Chunlong Zhao; Hang Dong; Qifu Xu; Yingjie Zhang
Journal:  RSC Adv       Date:  2021-06-17       Impact factor: 3.361

5.  Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs.

Authors:  Ewelina Węglarz-Tomczak; Michał Talma; Mirosław Giurg; Hans V Westerhoff; Robert Janowski; Artur Mucha
Journal:  Oncotarget       Date:  2018-06-29

6.  Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN).

Authors:  Isel Pascual; Pedro A Valiente; Gabriela García; Mario E Valdés-Tresanco; Yarini Arrebola; Lisset Díaz; Lotfi Bounaadja; Rosa María Uribe; Mae Chappé Pacheco; Isabelle Florent; Jean-Louis Charli
Journal:  Biochimie       Date:  2017-09-28       Impact factor: 4.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.